| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 9.99% | $26.5M | 9.27M | Deep Track Capital, LP | Jan 10, 2025 | |||
| ATAI Life Sciences N.V. | 7.5% | $19.8M | 6.91M | ATAI Life Sciences N.V. | Mar 5, 2025 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 3.7% | $9.76M | 3.41M | Millennium Management LLC | Dec 31, 2024 | |||
| Goldsmith George Jay | 2.4% | -6.67% | $6.41M | -$370K | 2.24M | -5.46% | George Jay Goldsmith | Mar 31, 2025 |
| CITADEL ADVISORS LLC | 1.7% | $3.34M | 1.17M | Kenneth Griffin | Dec 31, 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 393K | $1.12M | +$411K | $2.86 | 17 |
| 2024 Q4 | 30.9M | $117M | -$20.9M | $3.78 | 127 |
| 2024 Q3 | 32.8M | $206M | +$27.4M | $6.30 | 128 |
| 2024 Q2 | 28.4M | $172M | +$1.89M | $6.04 | 116 |
| 2024 Q1 | 27.4M | $228M | +$40.2M | $8.32 | 113 |
| 2023 Q4 | 23M | $201M | +$2.01M | $8.75 | 118 |
| 2023 Q3 | 22.2M | $164M | +$104M | $7.40 | 100 |
| 2023 Q2 | 8.29M | $68.6M | +$758K | $8.28 | 90 |
| 2023 Q1 | 8.18M | $81.3M | +$5.75M | $9.93 | 93 |
| 2022 Q4 | 7.59M | $61M | -$1.35M | $8.03 | 96 |
| 2022 Q3 | 7.27M | $78M | +$7.09M | $10.73 | 88 |
| 2022 Q2 | 6.57M | $71M | -$6.94M | $10.82 | 80 |
| 2022 Q1 | 7.52M | $96.9M | -$7.95M | $12.89 | 79 |
| 2021 Q4 | 7.53M | $166M | -$10.2M | $22.10 | 106 |
| 2021 Q3 | 7.38M | $221M | -$10.8M | $29.87 | 107 |
| 2021 Q2 | 7.48M | $285M | +$111M | $38.15 | 102 |
| 2021 Q1 | 4.51M | $166M | -$36.8M | $36.82 | 76 |
| 2020 Q4 | 5.4M | $257M | -$22.6M | $47.64 | 53 |
| 2020 Q3 | 5.49M | $192M | +$192M | $34.90 | 37 |
| 2020 Q2 | 1K | $38K | $0 | $38.00 | 1 |
| 2020 Q1 | 1K | $38K | $0 | $38.00 | 1 |
| 2019 Q4 | 1K | $38K | $0 | $38.00 | 1 |
| 2019 Q3 | 1K | $38K | $0 | $38.00 | 1 |
| 2019 Q2 | 1K | $38K | $0 | $38.00 | 1 |
| 2019 Q1 | 1K | $38K | $0 | $38.00 | 1 |